Mirvaso (brimonidine) Topical Gel, 0.33% from Galderma Laboratories is now available in a pump dispenser. Prescription Mirvaso is indicated for the treatment of the persistent facial redness associated with rosacea, and the new pump design was developed to deliver a consistent dose at each use.
“The availability of the Mirvaso Gel Pump offers a number of benefits to patients with facial erythema,” said Sandra Johnson, MD, board certified dermatologist at Johnson Dermatology in Fort Smith, Arkansas, and Galderma consultant. “Research proves that the majority of patients prefer a pump dispenser over a tube. As a frequent prescriber of Mirvaso Gel, I am excited for the introduction of this dosing option that is convenient to use for my patients.”
